Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/05/066795
CTRI/2024/05/066795
Not yet recruiting
Phase 2

A randomized clinical trial to evaluate the efficacy of oral administration of Yashtyadi Vati in Dwitiya Patalgata Dosha Dushti with reference to vitreous floaters. - NI

Sane Guruji Arogya Kendra0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H433- Other vitreous opacities

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: H433- Other vitreous opacities
Sponsor
Sane Guruji Arogya Kendra
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who have signs of Dwitiya Patalgata Dosha Dushti such as black spots, flies, mosquitoes, hairs, squiggly lines or spider webs.
  • •2\. Patients between the ages of 19 years to 70 years irrespective of gender, cast and socio\-economic condition.\[22]
  • •3\. Patients who have vitreous floaters on regular basis or suddenly.
  • •4\. Patients with both refractive errors – myopic and hypermetropic
  • •5\. Asymptomatic patients with high myopia.
  • •6\. Patients experiencing eye floaters either before or after any ophthalmic surgery and ophthalmic trauma.

Exclusion Criteria

  • •1\. Patients having known case of HIV, Tuberculosis, Rheumatic heart diseases.
  • •2\. Patients having known case of Diabetes, Hypertension may interfere with trial group so they are excluded.
  • •3\. Patient having history of glaucoma, retinal vein occlusion, macular edema and uveitis.
  • •4\. And any condition other than explained in inclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
A randomized clinical trial to evaluate the efficacy of catecholamine surge supression by oral azilsartan in patients with hypertensive intracerebral hemorrhageHypertensive intracerebral hemorrhage
JPRN-UMIN000014323Clinical Research Institute, Fujita Health University Hospital40
Recruiting
Phase 4
A randomized clinical trial to evaluate the efficacy of polyethylene glycol vs psyllium fiber to prevent rebleeding in patients hospitalized with bleeding diverticular disease.Bleeding Diverticular disease10017977
NL-OMON52735Elisabeth-Tweesteden ziekenhuis260
Not yet recruiting
Not Applicable
PREVENTIO
NL-OMON29193ot applicable260
Recruiting
Phase 3
A clinical trial to study the effect of Ayurveda in patients with duchenne muscular dystrophy
CTRI/2022/04/042342Dr Rashmi R
Completed
Phase 2
To study the effect of Ayurvedic formulations on PramehajanyaTimira/Diabetic Macular Edema.
CTRI/2022/06/043269ational Institute of Ayurveda30